Imovax rabies vaccine vials
Ended Awarded Last action
- Contract number
- SPE2DR26F7WTE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,725
Award facts
- Contract value 100% obligated
- $1,725.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,725.20 for IMOVAX Rabies Vaccine vials on December 18, 2025, with an ultimate completion date of December 19, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor specializing in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling competitive medical procurement requirements for the Defense Logistics Agency's Medical Supply Chain, with delivery orders spanning a wide range of pharmaceutical products and therapeutic domains. This rabies vaccine delivery order reflects the contractor's ongoing role in supporting the Department of Defense's medical supply operations through the DLA Troop Support Medical prime vendor platform, which enables flexible pharmaceutical supply across multiple federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26F7WTE?
SPE2DR26F7WTE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F7WTE worth?
The government has obligated $1,725 on SPE2DR26F7WTE.
Is contract SPE2DR26F7WTE an order under another contract?
Yes. SPE2DR26F7WTE is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WTE competed?
The extent of competition for SPE2DR26F7WTE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award